Historical record - last NADAC publication: 1/3/2020
Product Information
ZORTRESS 0.75 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $27.0419 per EA under NDC 00078041520. Its NADAC has been published 339 times since Jul 23, 2014.
The High Outlier badge above means this manufacturer's average price in the everolimus market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.75 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078041520
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
1/3/2020
Active Ingredients
EVEROLIMUSApproval Type
New Drug (NDA)
FDA Application
NDA021560On Market Since
4/22/2010
Pharmacological Classes
Price Statistics
The NADAC for ZORTRESS 0.75 MG TABLET has been published 339 times since Jul 23, 2014, and over the history we have for it it has risen 40.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $27.0419 per EA |
|---|---|
| All-time high | $27.0419 (Jan 13, 2021) |
| All-time low | $19.3093 (Jul 23, 2014) |
| Median price | $23.9517 |
| Average price | $23.6206 |
| Largest weekly change | +7.0% (Jul 15, 2015) |
| Weeks tracked | 339 |
| Tracking since | Jul 23, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 81% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ZORTRESS 0.75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZORTRESS 0.75 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $27.0419 per EA (NDC 00078041520), effective Jan 13, 2021.
How has the price of ZORTRESS 0.75 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZORTRESS 0.75 MG TABLET has risen 40.0%. It has been tracked across 339 weekly CMS publications since Jul 23, 2014.
What are the highest and lowest recorded NADAC prices for ZORTRESS 0.75 MG TABLET?
Since Jul 23, 2014, the NADAC for ZORTRESS 0.75 MG TABLET has ranged from a low of $19.3093 (Jul 23, 2014) to a high of $27.0419 (Jan 13, 2021), with a median of $23.9517 per EA.
Are there cheaper alternatives to ZORTRESS 0.75 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, EVEROLIMUS 0.75 MG TABLET, is $5.1927 per EA — about 81% below ZORTRESS 0.75 MG TABLET.
Who manufactures ZORTRESS 0.75 MG TABLET?
ZORTRESS 0.75 MG TABLET (NDC 00078041520) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification